Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.

Fan KH, Lin CY, Kang CJ, Lee LY, Huang SF, Liao CT, Chen IH, Ng SH, Wang HM, Chang JT.

PLoS One. 2014 Feb 24;9(2):e86922. doi: 10.1371/journal.pone.0086922. eCollection 2014.

2.

Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates.

Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao CT, Chang JT.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1024-9. doi: 10.1016/j.ijrobp.2009.06.064.

PMID:
20610038
3.

Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.

Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC.

Cancer. 2007 Aug 1;110(3):564-71.

4.

Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.

Chen WC, Lai CH, Fang CC, Yang YH, Chen PC, Lee CP, Chen MF.

Medicine (Baltimore). 2016 May;95(22):e3770. doi: 10.1097/MD.0000000000003770.

5.
6.

Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases.

Takahashi H, Yanamoto S, Yamada S, Umeda M, Shigeta T, Minamikawa T, Shibuya Y, Komori T, Shiraishi T, Asahina I, Yokoo S, Ri S.

Int J Oral Maxillofac Surg. 2014 Jun;43(6):680-5. doi: 10.1016/j.ijom.2013.11.013. Epub 2013 Dec 30.

PMID:
24387949
7.

Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.

Liao CT, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Chen IH, Chang KP, Huang SF, Kang CJ, Fang KH, Wang YC, Chang YL, Huang YC, Tsai CY, Yen TC.

Oral Oncol. 2013 Mar;49(3):230-6. doi: 10.1016/j.oraloncology.2012.09.010. Epub 2012 Oct 12.

PMID:
23063612
8.

Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.

Noble AR, Greskovich JF, Han J, Reddy CA, Nwizu TI, Khan MF, Scharpf J, Adelstein DJ, Burkey BB, Koyfman SA.

Anticancer Res. 2016 Feb;36(2):785-92.

PMID:
26851040
9.

Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes.

Liao CT, Lee LY, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Yen TC.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):930-7. doi: 10.1016/j.ijrobp.2010.07.1988. Epub 2010 Oct 8.

PMID:
20934267
10.

An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.

Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):137-48.

PMID:
9300748
11.

Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.

Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG.

Head Neck. 2000 Jan;22(1):34-41.

PMID:
10585603
12.

Impact of treatment sequence of multimodal therapy for advanced oral cavity cancer with mandible invasion.

Myers LL, Sumer BD, Truelson JM, Nedzi L, Perkins S, Hughes RS, Ahn C.

Otolaryngol Head Neck Surg. 2011 Dec;145(6):961-6. doi: 10.1177/0194599811417550. Epub 2011 Aug 2.

PMID:
21810773
13.

The prognostic significance of histological features in oral squamous cell carcinoma.

Larsen SR, Johansen J, Sørensen JA, Krogdahl A.

J Oral Pathol Med. 2009 Sep;38(8):657-62. doi: 10.1111/j.1600-0714.2009.00797.x. Epub 2009 Jun 25.

PMID:
19563504
14.

Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.

Tseng JR, Ho TY, Lin CY, Lee LY, Wang HM, Liao CT, Yen TC.

PLoS One. 2013 Nov 11;8(11):e79766. doi: 10.1371/journal.pone.0079766. eCollection 2013.

15.

Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY.

Am J Surg Pathol. 2005 Feb;29(2):167-78.

PMID:
15644773
16.

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C.

Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.

17.

Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.

Kademani D, Bell RB, Bagheri S, Holmgren E, Dierks E, Potter B, Homer L.

J Oral Maxillofac Surg. 2005 Nov;63(11):1599-605.

PMID:
16243176
18.

Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.

Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL.

Laryngoscope. 2005 Sep;115(9):1561-7.

PMID:
16148695
19.

The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.

Wenzel S, Sagowski C, Kehrl W, Metternich FU.

Eur Arch Otorhinolaryngol. 2004 May;261(5):270-5. Epub 2003 Sep 18.

PMID:
14504863
20.

Outcome analysis of patients with pN2 oral cavity cancer.

Liao CT, Huang SF, Chen IH, Kang CJ, Lin CY, Fan KH, Wang HM, Ng SH, Hsueh C, Lee LY, Tsao CK, Yen TC.

Ann Surg Oncol. 2010 Apr;17(4):1118-26. doi: 10.1245/s10434-009-0894-6. Epub 2010 Feb 5.

PMID:
20135357

Supplemental Content

Support Center